Hormones
Follow the links below to find trusted information about hormones.
Last reviewed: July 2016
Need more information?
These trusted information partners have more on this topic.
Found 1572 results
Pituitary hormones initiatives
This page contains information on the relation between human pituitary hormone treatment and Creutzfeldt-Jakob disease (CJD) as well as Government's initiatives for the control and prevention of CJD.
Read more on Department of Health website
Growth hormone - Lab Tests Online AU
To identify diseases and conditions caused by either a deficiency or overproduction of growth hormone (GH), to evaluate pituitary function, and to monitor the effectiveness of GH treatment
Read more on Lab Tests Online website
Thyroid gland and thyroid hormones - myDr.com.au
The thyroid gland produces thyroid hormones - the main ones being T3 (triiodothyronine) and T4 (thyroxine).
Read more on myDr website
Hormone replacement therapy - myDr.com.au
Hormone replacement therapy (HRT) is not a quick fix to the challenge of menopause, but it can be a useful tool in the overall management of menopause.
Read more on myDr website
FSH - Lab Tests Online AU
To evaluate the function of your pituitary gland which regulates the hormones that control your reproductive system
Read more on Lab Tests Online website
LH - Lab Tests Online AU
To evaluate the function of your pituitary gland, which regulates the hormones that control your reproductive system.
Read more on Lab Tests Online website
Thyroid diseases - Lab Tests Online AU
The thyroid is a small, butterfly-shaped gland just below the Adam's apple. This gland plays a very important role in controlling your body's metabolism, that is, how your body functions. It does this by producing thyroid hormones (thyroxine, or T4, and triiodothyronine, or T3), chemicals that travel through your blood to every part of your body. Thyroid hormones tell your body how fast to work and use energy.
Read more on Lab Tests Online website
Iodine Facts | Nutrition Australia
Iodine is an essential trace element and an integral component of thyroid hormones. Thyroid hormones are required for normal growth and development of tissues and maturation of our bodies. Iodine deficiency is the most common preventable cause of mental retardation in the world; obtaining iodine through the food supply is therefore paramount.
Read more on Nutrition Australia website
Zomacton 4 mg Powder for Injection - myDr.com.au
Zomacton 4 mg Powder for Injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Genotropin MiniQuick Powder for Injection - myDr.com.au
Genotropin MiniQuick Powder for Injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 705 results
Gonadotrophin-releasing hormone antagonists versus GnRH agonist in subfertile couples undergoing assisted reproductive technology | Cochrane
Gonadotrophin-releasing hormone antagonists versus GnRH agonist in subfertile couples undergoing assisted reproductive technology
Read more on Cochrane (Australasian Centre) website
Gonadotrophin-releasing hormone antagonists in subfertile couples undergoing ovulation induction as part of an assisted conception program | Cochrane
Read more on Cochrane (Australasian Centre) website
Growth hormone in in-vitro fertilisation | Cochrane
Before starting an in-vitro fertilisation cycle, some women need help to ovulate and the use of growth hormone therapy may help these women. This aims to reduce the use of gonadotropin therapy to stimulate ovulation, a hormone that can cause multiple pregnancy. The review of trials found no evidence that growth hormone helps improve birth rates in women who are undergoing ovulation induction prior to in-vitro fertilisation. However there is some evidence of increased pregnancy and birth rates in women who are considered 'poor responders' to in-vitro fertilisation. More research is needed.
Read more on Cochrane (Australasian Centre) website
Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia | Cochrane
A systematic overview of randomised trials does not provide sufficient evidence to determine whether thyroid hormone treatment of preterm infants with transiently low thyroid hormone levels results in changes in neonatal outcomes or reductions in developmental impairments. Extremely premature infants frequently have transiently low thyroid hormone levels in the first weeks after birth. These low thyroid hormone levels are associated with an increased incidence of complications and death in the newborn period and longer term developmental impairments. Thyroid hormone therapy might prevent these problems. One small trial comparing thyroid hormone treatment to no treatment of infants with transiently low thyroid hormone levels reported no benefit from treatment of these infants. However, this is insufficient evidence to determine if thyroid hormone treatment is effective. Further research is needed.
Read more on Cochrane (Australasian Centre) website
Thyroid hormones for preventing neurodevelopmental impairment in preterm infants | Cochrane
No evidence from trials that thyroid hormone therapy is effective in preventing problems such as respiratory distress syndrome in preterm babies. Thyroid hormones are needed for the normal growth and maturity of the central nervous system, as well as the heart and lungs. Children born without sufficient thyroid hormones can develop serious mental retardation. It is believed that low levels of thyroid hormones in the first few weeks of life (transient hypothyroxinemia) in preterm babies born before 34 weeks may cause this abnormal development. The review of trials found no evidence that using thyroid hormones in preterm babies is effective in reducing the risk of problems caused by insufficient thyroid hormones.
Read more on Cochrane (Australasian Centre) website
Recombinant growth hormone for idiopathic short stature in children and adolescents | Cochrane
There is some evidence that recombinant human growth hormone improves short term growth and (near) final adult height in children with idiopathic short stature.
Read more on Cochrane (Australasian Centre) website
Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants | Cochrane
A systematic review of the data from randomised controlled trials provides no evidence that routine thyroid hormone therapy is effective in preventing problems in preterm babies or improves their developmental outcomes. Thyroid hormones are needed for the normal growth and maturity of the central nervous system, as well as the heart and lungs. Children born without sufficient thyroid hormones can develop serious mental retardation. It is believed that low levels of thyroid hormones in the first few weeks after birth (transient hyperthyroxinaemia) in preterm babies born before 34 weeks may contribute to this abnormal development. The review of trials found no evidence that using thyroid hormones routinely in preterm babies is effective in reducing the risk of problems caused by transiently low levels of thyroid hormones.
Read more on Cochrane (Australasian Centre) website
Human growth hormone for treating burns and skin graft donor sites | Cochrane
Growth hormone is produced by the pituitary gland. For decades, it could only be obtained by extraction from pituitary glands but more recently it has been produced through genetic engineering and made available for therapy as recombinant human growth hormone (rhGH). The aim of this review was to determine the effects of rhGH when used to treat burns and skin graft donor sites and to determine its safety compared with other treatments.
Read more on Cochrane (Australasian Centre) website
Thyroid hormone replacement for subclinical hypothyroidism | Cochrane
Subclinical hypothyroidism is a condition where some laboratory findings point at a thyroid gland not working properly. Patients with subclinical hypothyroidism may have vague, non-specific symptoms of actual hypothyroidism (for example dry skin, cold skin or feeling colder, constipation, slower thinking, poor memory) but these thyroid-related symptoms are not specific, that is why the diagnosis is based on test results. The fundamental question regarding people with subclinical hypothyroidism is whether they should be treated with thyroid hormones. To answer this question twelve studies of six to 14 months duration involving 350 people were analysed. Thyroid hormone therapy for subclinical hypothyroidism did not result in improved survival or decreased cardiovascular morbidity (for example less heart attacks or strokes). Data on health-related quality of life and symptoms did not demonstrate significant differences between placebo and thyroid hormone therapy. Some evidence indicated that thyroid hormone had some effects on blood lipids and technical measurements of heart function. Adverse effects were inadequately addressed in most of the included studies and have to be urgently investigated in future studies, especially in older patients.
Read more on Cochrane (Australasian Centre) website
Adjuvant gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal women | Cochrane
Adjuvant gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal women
Read more on Cochrane (Australasian Centre) website
